- Home
- PROF vs SCPH Comparison
PROF vs SCPH Comparison
Compare PROF & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- SCPH
- Stock Information
- Founded
- PROF N/A
- SCPH 2013
- Country
- PROF Canada
- SCPH United States
- Employees
- PROF N/A
- SCPH N/A
- Industry
- PROF Medical/Dental Instruments
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- PROF Health Care
- SCPH Health Care
- Exchange
- PROF Nasdaq
- SCPH Nasdaq
- Market Cap
- PROF 149.7M
- SCPH 173.6M
- IPO Year
- PROF N/A
- SCPH 2017
- Fundamental
- Price
- PROF $6.38
- SCPH $3.84
- Analyst Decision
- PROF Strong Buy
- SCPH Strong Buy
- Analyst Count
- PROF 2
- SCPH 3
- Target Price
- PROF $11.50
- SCPH $14.00
- AVG Volume (30 Days)
- PROF 50.0K
- SCPH 289.6K
- Earning Date
- PROF 08-07-2025
- SCPH 08-13-2025
- Dividend Yield
- PROF N/A
- SCPH N/A
- EPS Growth
- PROF N/A
- SCPH N/A
- EPS
- PROF N/A
- SCPH N/A
- Revenue
- PROF $11,862,000.00
- SCPH $41,982,000.00
- Revenue This Year
- PROF $71.17
- SCPH $108.95
- Revenue Next Year
- PROF $134.25
- SCPH $73.83
- P/E Ratio
- PROF N/A
- SCPH N/A
- Revenue Growth
- PROF 75.01
- SCPH 138.10
- 52 Week Low
- PROF $3.90
- SCPH $1.94
- 52 Week High
- PROF $11.42
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- PROF 69.47
- SCPH 56.83
- Support Level
- PROF $6.69
- SCPH $3.86
- Resistance Level
- PROF $7.02
- SCPH $4.17
- Average True Range (ATR)
- PROF 0.40
- SCPH 0.23
- MACD
- PROF 0.09
- SCPH -0.06
- Stochastic Oscillator
- PROF 69.53
- SCPH 33.33
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.